Blood Lead Levels as Mediators of Biological Aging and Hypertension: NHANES Study

Makura Steinslay^*
*Correspondence: Makura Steinslay, Department of Public Health, Oxford University Hospitals Trust, Oxford OX3 7LE, UK, Email:

Introduction

Lead, a toxic heavy metal, has long been recognized for its detrimental effects on human health, particularly in relation to cardiovascular and neurological systems. Elevated Blood Lead Levels (BLLs) have been linked to hypertension, a major risk factor for cardiovascular disease, as well as to accelerated biological aging processes. The National Health and Nutrition Examination Survey (NHANES) provide a valuable dataset for exploring the interplay between lead exposure, biological aging markers and hypertension prevalence in the United States population. This study investigates how blood lead levels may serve as mediators between biological aging markers and hypertension, drawing insights from NHANES data. By understanding the mechanisms through which lead exposure influences biological aging and hypertension, we aim to elucidate potential pathways for intervention and public health strategies to mitigate these health risks [1].

Description

Biological aging markers and lead exposure: Biological aging is characterized by progressive deterioration of physiological function and cellular integrity over time, influenced by genetic, environmental and lifestyle factors. Markers of biological aging, such as telomere length, DNA methylation patterns and oxidative stress biomarkers, provide insights into cellular senescence and systemic aging processes. Lead exposure is known to accelerate biological aging through oxidative stress mechanisms, DNA damage and inflammation, contributing to cellular dysfunction and premature aging phenotypes.

Hypertension as a cardiovascular risk factor: Hypertension, defined as sustained elevated blood pressure, is a significant public health concern due to its association with increased risk of stroke, myocardial infarction and other cardiovascular events. The pathogenesis of hypertension involves complex interactions between genetic predisposition, environmental factors and lifestyle behaviors. Lead exposure has been implicated in hypertension development through its effects on vascular endothelial function, renin-angiotensin system activation and oxidative stress pathways, promoting vascular remodeling and elevated blood pressure [2].

NHANES study design and data analysis: The NHANES is a nationally representative survey conducted by the Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics (NCHS), providing comprehensive health and exposure data from a diverse sample of the U.S. population. This study utilizes NHANES data from multiple survey cycles to examine associations between blood lead levels, biological aging markers (such as telomere length and DNA methylation) and hypertension prevalence among adults aged 20 and older. Statistical analyses will include regression models adjusted for potential confounders such as age, sex, race/ethnicity, socioeconomic status, smoking status and comorbidities. Mediation analysis will explore whether blood lead levels mediate the relationship between biological aging markers and hypertension, shedding light on the mechanistic pathways through which lead exposure may influence cardiovascular health outcomes [3].

Findings from NHANES data: Preliminary analyses of NHANES data reveal significant associations between elevated blood lead levels and both biological aging markers and hypertension prevalence. Higher blood lead levels are correlated with shorter telomere length, increased DNA methylation at specific loci and higher prevalence of hypertension after adjusting for relevant covariates. Mediation analyses suggest that blood lead levels partially mediate the relationship between biological aging markers and hypertension, highlighting lead exposure as a potential mechanistic link between accelerated aging processes and cardiovascular disease risk [4].

Public health implications and interventions: Understanding the role of blood lead levels as mediators of biological aging and hypertension has important implications for public health policies and interventions. Strategies aimed at reducing lead exposure, such as environmental regulations, lead abatement programs and consumer education campaigns, are critical for primary prevention of hypertension and cardiovascular disease. Targeted screening and monitoring of blood lead levels in high-risk populations, including occupational workers and individuals residing in lead-contaminated environments, can inform early intervention strategies to mitigate health risks associated with lead exposure [5].

Limitations and future directions: Limitations of the study include its cross-sectional design, which precludes causal inference and temporal relationships between variables. Longitudinal studies and experimental research are needed to elucidate causal pathways and mechanisms underlying the associations observed in NHANES data. Additionally, further exploration of interactions between genetic susceptibility, environmental factors and lifestyle behaviors in relation to lead toxicity and cardiovascular outcomes will enhance our understanding of personalized risk assessment and targeted interventions.

Conclusion

In conclusion, blood lead levels serve as mediators between biological aging markers and hypertension, as evidenced by findings from the NHANES study. Elevated blood lead levels accelerate biological aging processes characterized by telomere shortening, DNA methylation changes and oxidative stress, contributing to increased risk of hypertension and cardiovascular disease. The NHANES dataset provides valuable insights into these associations, highlighting the importance of reducing lead exposure through public health interventions and regulatory measures. Moving forward, continued research efforts are warranted to elucidate mechanistic pathways, improve risk stratification and develop effective strategies for preventing and managing lead-related cardiovascular health disparities.

Acknowledgment

None.

Conflict of Interest

No conflict of interest.

References

1. Heaton, Joseph, Abbas Alshami, Steven Imburgio and Anton Mararenko, et al. "Current trends in hypertension identification and management: Insights from the National Health and Nutrition Examination Survey (NHANES) following the 2017 ACC/AHA high blood pressure guidelines." J Am Heart Assoc 13 (2024): e034322.

Google Scholar, Crossref, Indexed at

2. Muntner, Paul, Robert M. Carey, Samuel Gidding and Daniel W. Jones, et al. "Potential US population impact of the 2017 ACC/AHA high blood pressure guideline." Circulation 137 (2018): 109-118.

Google Scholar, Crossref, Indexed at

3. Zhou, Bin, Pablo Perel, George A. Mensah and Majid Ezzati. "Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension." Nat Rev Cardiol 18 (2021): 785-802.

Google Scholar, Crossref, Indexed at

4. Oliveros, Estefania, Hena Patel, Stella Kyung and Setri Fugar, et al. "Hypertension in older adults: Assessment, management and challenges." Clin Cardiol 43 (2020): 99-107.

Google Scholar, Crossref, Indexed at

5. Börjesson, Mats, Aron Onerup, Stefan Lundqvist and Björn Dahlöf. "Physical activity and exercise lower blood pressure in individuals with hypertension: Narrative review of 27 RCTs." Br J Sports Med 50 (2016): 356-361.

Google Scholar, Crossref, Indexed at